News

Tell us about your exciting accomplishments!

OVPR staff is excited about the breakthroughs in research and scholarly accomplishments on our campus. If you have been awarded a grant, submitted a paper for publication or been notified that your research is being published in a scholarly journal, please contact us at hscora@ouhsc.edu so we can share the news with the rest of the OUHSC research community.

"The ORA submission process: A review for new investigators"
New PI Training 04-20-16 Final

Other helpful information

On this page, you will also find useful Institutional Data that you may be asked to provide when submitting a proposal.   Please let us know if there is additional information or links you would like to see on our site. Simply complete our Suggestion Form.

ORA News & Announcements Monday, August 19, 2019

ORA Research News - Monday, August 19, 2019

 

 

National Cancer Institute Predoctoral to Post-Doctoral Fellow Transition Award (F99/K00)

OUHSC can nominate one graduate student in their 3rd or 4th year since beginning graduate school who is

working towards their PhD degree to apply for an F99/K00 award from the NCI

(https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-19-057.html).  Note: Dual-degree, or professional doctorate/

clinical degree students are not eligible.

  1. Purpose:  The purpose of the NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) is to

encourage and retain outstanding graduate students recognized by their institutions for their high potential

and strong interest in pursuing careers as independent cancer researchers. The award will facilitate the

transition of talented graduate students into successful cancer research postdoctoral appointments, and

provide opportunities for career development activities relevant to their long-term career goals of becoming

independent cancer researchers. Final F99/K00 application due date at NIH is December 4th.

  1. Eligibility:  3rd or 4th year graduate student working on a specific cancer-related Ph.D. dissertation project

that wants to transition in the next 1-2 years to a postdoctoral fellowship research in cancer research.

  1. Submitting a pre-proposal:  A pre-proposal must be submitted to the Graduate College by September 6th, 2019.

Pre-proposals must include:

  1. Specific Aims Page: there are 2 required Specific Aims as follow:
  1. Aim 1: The Dissertation Research Project
  2. Aim 2: The Postdoctoral Research Direction
  1. Letter of support from F99 sponsor(s)
  2. Full CV of applicant including academic record and prior research experience
  3. NIH Biosketch of sponsor(s)
  1. Submit the pre-proposal as a single file in PDF format to:  Gillian-Air@ouhsc.edu in the Graduate College
  2. Pre-proposals will be reviewed by a panel of expert cancer researchers and educators.
  3. Questions: contact Darrin-akins@ouhsc.edu or Gillian-air@ouhsc.edu

 

 

NIH Contract SBIR Solicitation

NIH has SBIR funding for health related startup or small business (e.g. pharma, health IT, medical devices, diagnostics,

mobile health, etc) (https://grants.nih.gov/grants/guide/notice-files/NOT-OD-19-121.html). This is not the normal NIH

“grant” SBIR – it comes out once a year and is the best chance anyone has to secure NIH SBIR funding. A key difference

with the NIH Contract SBIR opportunity is that you must respond to a specific topic – and there is no guarantee these topics

will be back next year (see attached).  The Oklahoma Catalyst Program can assist if you are interested in applying:

https://www.okcatalyst.com/.

https://research.ouhsc.edu/Portals/1329/Assets/Documents/NIH Contract SBIR Topics.docx?ver=2019-08-18-153311-077

 

The Office of Technology Development will offer the Innovation to Impact Series Session 1“Patents 101: First Do No

Harm – How to Write and Speak About Your Invention Without Losing US or Foreign Patent Rights.” Learn what is

a patent; How/why does a public disclosure affect patentability; Types of public disclosures; How to publish without hurting

your patent rights; and Key milestones of the patent process. Chris Corbett, Director of Intellectual Property, will be presenting.

This session will occur on August 28th  from Noon- 1:00 pm in Biomedical Research Center Building,  Room 103. Lunch will

be provided.  Please RSVP to rashaffer@ou.edu by August 22nd. Space is limited to the first 15 attendees.

 

 

DEADLINE UPDATE: IBEST-OUHSC Funding for Interdisciplinary Research – Request for Applications to support

collaborative research activities between OUHSC researchers and OU-Norman researchers in the area of biomedical engineering

Deadline September 6, 2019 – please see guidelines and face page attached

https://research.ouhsc.edu/Portals/1329/Assets/Documents/2019-IBEST-OUHSC-CollaborationAnnouncement_final.pdf?ver=2019-07-01-074315-223

https://research.ouhsc.edu/Portals/1329/Assets/Documents/2019-IBEST-OUHSC-CollaborationCover page_final.pdf?ver=2019-07-01-074315-193

 

OSCTR TPIR Trainee Program

Seeking applicants for the sixth year of the research training program Translating Practice into

Research (TPIR). TPIR is a program for healthcare professionals, clinical investigators, and basic

Scientists and it is funded by the NIH Oklahoma Shared Clinical and Translational Resources grant. The goal

of the TPIR trainee program is to produce a group of clinicians and scientists who have the ability to

translate their clinical observations and ideas for improving practice into practical and feasible research

projects. Attached is a detailed description and application due September 3, 2019.

http://osctr.ouhsc.edu/translating-practice-research-program

https://research.ouhsc.edu/Portals/1329/Assets/Documents/OSCTR TPIR information 2019.pdf?ver=2019-08-12-083211-813

 

Harold Hamm Diabetes Center (HHDC) - Please mark your calendar for the 16th Annual Harold Hamm

Diabetes Center Research Symposium.  This event will be held on Friday, November 15, 2019 at the Samis Education

Center at Children’s Hospital in Oklahoma City. Deadline for abstracts will be announced later this summer.  Additional details

will be posted on http://haroldhamm.org/  Questions?  Please email

Katie-Hoefling@ouhsc.edu

 

 

NIH NOTICES

 

Notice of Extension of the Response Date for NOT-AT-19-030 "Request for Information (RFI): Important Considerations for

Potential Creation of an Open-Access Repository or Database for Physiological and Anatomical Ontology of Acupoints"

(NOT-AT-19-031)
https://grants.nih.gov/grants/guide/notice-files/NOT-AT-19-031.html

 

Notice of Correction to Award Budget for RFA-DA-19-019 " HEAL Initiative: Americas Startups and Small Businesses Build

Technologies to Stop the Opioid Crisis (R43/R44 - Clinical Trial Optional)" (NOT-DA-19-057)
https://grants.nih.gov/grants/guide/notice-files/NOT-DA-19-057.html

 

Notice of Correction to Award Budget for RFA-DA-19-020 " HEAL Initiative: Americas Startups and Small Businesses Build

Technologies to Stop the Opioid Crisis (R41/R42 - Clinical Trial Optional)" (NOT-DA-19-067)
https://grants.nih.gov/grants/guide/notice-files/NOT-DA-19-067.html

 

Notice of Clarification for Suggested Tables for PAR-19-218 Undergraduate Research Initiative for Student Enhancement

(RISE) (T34) (NOT-GM-19-055)
https://grants.nih.gov/grants/guide/notice-files/NOT-GM-19-055.html

 

Notice of Clarification for Suggested Tables for PAR-19-219 "Maximizing Access to Research Careers (T34)"
(NOT-GM-19-056)
https://grants.nih.gov/grants/guide/notice-files/NOT-GM-19-056.html

 

Notice to Extend the Expiration Date of PAR-18-227, "Development and Application of PET and SPECT Imaging Ligands as

Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)"

(NOT-MH-19-037)
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-19-037.html

 

Notice of NINR Withdrawal from Participation in PAR-19-333 "SBIR/STTR Commercialization Readiness Pilot (CRP)

Program Technical Assistance and Late Stage Development (SB1, R44) Clinical Trial Not Allowed" (NOT-NR-19-007)
https://grants.nih.gov/grants/guide/notice-files/NOT-NR-19-007.html

 

Notice of NINR Withdrawal from Participation in PAR-19-334 "SBIR/STTR Commercialization Readiness Pilot (CRP) P

rogram Technical Assistance (SB1, R44) Clinical Trial Not Allowed" (NOT-NR-19-008)
https://grants.nih.gov/grants/guide/notice-files/NOT-NR-19-008.html

 

Notice of NINR Withdrawal from Participation in PAR-19-335 "SBIR/STTR Commercialization Readiness Pilot (CRP)

Program Technical Assistance and Late Stage Development (SB1, R44) Clinical Trial Required"
(NOT-NR-19-009)
https://grants.nih.gov/grants/guide/notice-files/NOT-NR-19-009.html

 

Notice of Change to Key Dates for PAS-19-210 "Progression Markers for Cognitive Impairment in Parkinson's Disease

Dementia (R01 Clinical Trial Not Allowed)" (NOT-NS-19-081)
https://grants.nih.gov/grants/guide/notice-files/NOT-NS-19-081.html

 

New Expiration Date for PAR-OH-14-246 NIOSH Support for Conferences and Scientific Meetings (R13)
(NOT-OH-19-007)
https://grants.nih.gov/grants/guide/notice-files/NOT-OH-19-007.html

 

New Expiration Date for PAR-14-229 NIOSH Support for Conferences and Scientific Meetings (U13)
(NOT-OH-19-008)
https://grants.nih.gov/grants/guide/notice-files/NOT-OH-19-008.html

 

Notice of Change to Funding Opportunity in PAR-19-244 "International Research Ethics Education and Curriculum

Development Award (R25 Clinical Trial Not Allowed)" (NOT-TW-19-006)
https://grants.nih.gov/grants/guide/notice-files/NOT-TW-19-006.html

 

Notice of Intent to Publish an NHLBI Funding Opportunity Announcement for STIMULATE-2 (R61/R33 Clinical Trial

Required) (NOT-HL-19-715)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-19-715.html

 

Notice of Special Interest for Small Business Research for Methods Development in Natural Products Chemistry

(NOT-AT-19-025)
https://grants.nih.gov/grants/guide/notice-files/NOT-AT-19-025.html

 

Notice of Special Interest: NCI's Research Interests to Improve Interprofessional Teamwork and Coordination During

Cancer Diagnosis and Treatment (NOT-CA-19-059)
https://grants.nih.gov/grants/guide/notice-files/NOT-CA-19-059.html

 

 

Please Note:  When only one application is allowed per Institution according to the sponsor

instructions, a one-page letter of intent summarizing the proposed project should be submitted

to the Vice President for Research at least one month prior to the application deadline (unless

otherwise noted).  The letters of intent will be reviewed and a single application will be chosen  

for submission from the University.

 

NIH DEADLINES

 

Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) (PAR-19-328)
Deadlines October 11, 2019 and February 11, 2020

https://grants.nih.gov/grants/guide/pa-files/PAR-19-328.html

 

Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial

Required) (PAR-19-329) – Deadlines October 11, 2019 and February 11, 2020

https://grants.nih.gov/grants/guide/pa-files/PAR-19-329.html

Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)

(PAR-19-330 - Deadline October 11, 2019 and February 11, 2020

https://grants.nih.gov/grants/guide/pa-files/PAR-19-330.html

 

SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development

(SB1, R44) Clinical Trial Not Allowed (PAR-19-333) - Deadline September 5, 2019 and January 5, 2020
https://grants.nih.gov/grants/guide/pa-files/PAR-19-333.html

 

SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, R44) Clinical Trial Not

Allowed (PAR-19-334) - Deadline September 5, 2019 and January 5, 2020

https://grants.nih.gov/grants/guide/pa-files/PAR-19-334.html

 

SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development

(SB1, R44) Clinical Trial Required (PAR-19-335) – Deadline September 5, 2019 and January 5, 2020
https://grants.nih.gov/grants/guide/pa-files/PAR-19-335.html

 

Limited Competition: Competitive Revision Awards for the Clinical and Translational Science Award (CTSA) Program

(U54 Clinical Trial Optional) (PAR-19-337) - Deadline September 25, 2019 and September 25, 2020 

https://grants.nih.gov/grants/guide/pa-files/PAR-19-337.html

 

Limited Competition: Renewals of, and Revisions and Resubmissions to, the Longitudinal Early-onset Alzheimers

Disease Study (LEADS) Cooperative Agreement (U01 Clinical Trial Not Allowed) (PAR-19-338)
Deadline November 5, 2019 and March 5, 2020

https://grants.nih.gov/grants/guide/pa-files/PAR-19-338.html

 

The Biological Mechanisms of Metformin Effects on Aging and Longevity (R01 Clinical Trial Not Allowed)
(RFA-AG-20-044) - Deadline January 21, 2020 

https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-20-044.html

 

Technologies to Advance Precision Medicine Diagnosis and Treatment of Infertility, Reproductive Tract and

Gynecologic Disorders Affecting Fertility (R43/R44 Clinical Trial Optional) (RFA-HD-20-010)
Deadline December 3, 2019

https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-20-010.html

 

Circadian Patterns of Gene Expression Associated with Disease (R01 - Clinical Trial Optional) (RFA-HL-20-016)

Deadline October 7, 2019

https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-20-016.html

Print